1 The same mechanisms apply to the hip, which carries 2.5 to 3 times body weight when walking, so the benefit is biologically plausible, but Wegovy hasnt been tested in a published hip trial
Benefits Patients using Semaglutide often experience significant weight loss and improved blood sugar levels
In a clinical trial of more than 3,000 adults with obesity, participants who received the highest dose of orforglipron, 36 milligrams, lost 11.2% of their body weight -- about 25 pounds on average -- over more than 16 months
Patients should discuss the evidence, potential benefits, costs, and limitations with their healthcare provider before commencing treatment
Proactively addressing side effects allows patients to optimize their semaglutide therapy while minimizing any associated risks
While more research is needed, these studies show the wide potential of semaglutide to help with various health issues